NASDAQ:CARA
Cara Therapeutics Stock News
$0.750
-0.0551 (-6.84%)
At Close: May 17, 2024
ST.GALLEN, Switzerland & STAMFORD, Conn.--(BUSINESS WIRE)--Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the Europ
Cara Therapeutics' (CARA) Korsuva NDA Gets FDA Priority Review
10:37am, Monday, 08'th Mar 2021
The FDA accepts Cara Therapeutics (CARA) and Vifor Pharma's NDA for Korsuva injection under a priority review to treat moderate-to-severe pruritus in hemodialysis patients. Shares rise.
CARA Stock Price Increases Over 15% Pre-Market: Why It Happened
05:03am, Monday, 08'th Mar 2021
The stock price of Cara Therapeutics Inc (NASDAQ: CARA) increased by over 15% pre-market. This is why it happened.
ST.GALLEN, Switzerland & STAMFORD, Conn.--(BUSINESS WIRE)--Regulatory News: Vifor Pharma and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the U.S. Food and Drug Administration (FDA) has
Cara Therapeutics, Inc.'s (CARA) CEO Derek Chalmers on Q4 2020 Results - Earnings Call Transcript
10:38pm, Thursday, 25'th Feb 2021
Cara Therapeutics, Inc.'s (CARA) CEO Derek Chalmers on Q4 2020 Results - Earnings Call Transcript
Preview: Cara Therapeutics's Earnings
10:13am, Wednesday, 24'th Feb 2021
On Thursday, February 25, Cara Therapeutics (NASDAQ:CARA) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Are Options Traders Betting on a Big Move in Cara Therapeutics (CARA) Stock?
09:47am, Friday, 08'th Jan 2021
Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.
Cara Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 06'th Jan 2021
STAMFORD, Conn., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allev
STAMFORD, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allev
Cara Therapeutics Inks A Potential Blockbuster On Its Hands
10:48am, Thursday, 17'th Dec 2020
The opioid industry is an ~$50 billion annual business, but opioids are very harmful to the body and extremely addictive. CARA has a drug that is finishing its trials and expectation is that an NDA wi
- Topline data expected in first half of 2021 -
Cara Therapeutics to Present at Multiple Upcoming Investor Conferences
07:00am, Wednesday, 11'th Nov 2020
STAMFORD, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q3 2020 Results - Earnings Call Transcript
08:01pm, Monday, 09'th Nov 2020
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q3 2020 Results - Earnings Call Transcript
Cara Therapeutics Reports Third Quarter 2020 Financial Results
04:01pm, Monday, 09'th Nov 2020
– Conference call today at 4:30 p.m. ET –
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020
04:01pm, Monday, 02'nd Nov 2020
STAMFORD, Conn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
